03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Tiapridal Tablets* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Winthrop Industrie |
Origin | France |
Manufacturer | Sanofi Winthrop Industrie |
Origin | France |
ATC | N05AL03 |
Tiapridal Tablets* :
Tiapridal Tablets* :
Tiapridal Tablets* :
Tiapridal Tablets* :
Tiapridal Tablets* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Tiapridal Tablets* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agitation | Common |
Agranulocytosis | Not known |
Akathisia | Uncommon |
Amenorrhoea (amenorrhea) | Uncommon |
Asthenia | Common |
Blood creatine phosphokinase increased | Not known |
Breast pain | Uncommon |
Cardiac arrest | Not known |
Cephalea | Common |
Confusion | Not known |
Consciousness loss | Not known |
Constipation | Not known |
Convulsion | Not known |
Deep vein thrombosis | Not known |
Dizziness | Common |
Dyskinesia | Rare |
Dystonia | Uncommon |
Extrapyramidal symptoms | Common |
Fall | Not known |
Fatigue | Common |
Galactorrhoea | Uncommon |
Gynecomastia (Gynaecomastia) | Uncommon |
Hallucination | Not known |
Hepatic enzyme increased | Not known |
Hypersalivation | Common |
Hypertonia | Common |
Hypokinesia | Common |
Hyponatraemia (Hyponatremia) | Not known |
Hypotension | Not known |
Ileus | Not known |
Impotence | Uncommon |
Inappropriate antidiuretic hormone secretion (SIADH) | Not known |
Indifference | Common |
Insomnia | Common |
Intestinal obstruction | Not known |
Leucopenia (Leukopenia) | Not known |
Maculopapular rash | Not known |
Mammary hypertrophy | Uncommon |
Movements involuntary | Not known |
Neuroleptic malignant syndrome | Not known |
Neutropenia | Not known |
Oculogyric crisis | Uncommon |
Orthostatic hypotension | Not known |
Pneumonia aspiration | Not known |
Prolactine increased | Uncommon |
Pulmonary embolism | Not known |
QT interval prolonged (QT prolongation) | Not known |
Rash erythematous | Not known |
Rhabdomyolysis | Not known |
Shakiness | Common |
Skin rash | Not known |
Somnolence | Common |
Spasmodic torticollis | Uncommon |
Sudden death | Not known |
Syncope | Not known |
Tardive dyskinesia | Not known |
Thromboembolism venous | Not known |
Torpor | Common |
Torsade de pointes | Not known |
Trismus | Uncommon |
Urticaria | Not known |
Ventricular arrhythmia | Not known |
Ventricular fibrillation | Not known |
Ventricular tachycardia | Not known |
Vertigo | Common |
Weight increased (weight gain) | Uncommon |
Withdrawal syndrome neonatal | Not known |
Tiapridal Tablets* :
NB : Products With Same Indication |
Different Units By MoH Code
Tiapridal Tablets* MoH 3082 :
Form | Tablet |
Packaging | Blisters (Al/PVC) |
Package Size | Box of 20 |
Strength | 100mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 24319/79 |
Submission date | 01/01/1979 |
Registration Year | 1979 |
Archived Date | 2018 |
Price Comparison
● Country: | Czech Republic | |
● Package Size: | 50 | |
● Public Price: | 137.88 CZK | ( 526,563.72 LBP ) |
● Pack size unit used: | 50 | |
● Cost/Unit: | 2,7576 CZK | ( 7,638.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 20 | |
● Public Price: | 9.74 EUR | ( 943,572.24 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,487 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 20 | |
● Public Price: | 19.9 SAR | ( 470,436.00 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,995 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Cyprus | |
● Package Size: | 20 | |
● Public Price: | 6.53 EUR | ( 632,600.28 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,3265 EUR | ( 0.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 29/04/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Switzerland | |
● Package Size: | 20 | |
● Public Price: | 14.4 CHF | ( 1,489,248.00 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,72 CHF | ( 0.00 LBP ) |
● Exfactory Price: | 5.38 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 20 | |
● Public Price: | 2.1 JOD | ( 262,964.10 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,105 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 1.6 JOD | ( 200353.6 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 25/05/2020 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 20 | |
● Public Price: | 3.17 EUR | ( 307,096.92 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,1585 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Portugal | |
● Package Size: | 20 | |
● Public Price: | 4.48 EUR | ( 434,004.48 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,224 EUR | ( 0.00 LBP ) |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde | |
● Pricing Date: | 22/04/2019 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 20 | |
● Public Price: | 11.32 EUR | ( 1,096,636.32 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,566 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 4.32 EUR | ( 418504.32 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 20 | |
● Public Price: | 11.5 AED | ( 277,851.50 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,575 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 9.58 AED | ( 231462.38 LBP ) |
● Pricing Date: | 16/11/2019 | |
● Type: | Medicine Withdrawn |
● Country: | Germany |
● Package Size: | 20 |
● Medica Comments: | Not available in the country of origin |
● Pricing Date: | 24/10/2020 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File